WallStreetZenWallStreetZen

NYSE: DBD
Diebold Nixdorf Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for DBD

Based on 2 analysts offering 12 month price targets for Diebold Nixdorf Inc

Min Forecast
$70.00+18.44%
Avg Forecast
$75.00+26.9%
Max Forecast
$80.00+35.36%

Should I buy or sell DBD stock?

Based on 2 analysts offering ratings for Diebold Nixdorf Inc.

Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Our proven Zen Rating quant model agrees with analyst consensus with a "Strong Buy" rating. Learn More

Be the first to know when Wall Street analysts revise their DBD stock forecasts and price targets.

DBD stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-08-19
lockedlocked$00.00+00.00%2025-08-07

1 of 1

Forecast return on equity

Is DBD forecast to generate an efficient return?

Company
20.1%
Industry
44.66%
Market
-21.41%
DBD's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is DBD forecast to generate an efficient return on assets?

Company
5.9%
Industry
15.65%
DBD is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

DBD earnings per share forecast

What is DBD's earnings per share in the next 2 years based on estimates from 1 analyst?

Avg 1 year Forecast
$3.47
Avg 2 year Forecast
$6.02

DBD revenue forecast

What is DBD's revenue in the next 2 years based on estimates from 1 analyst?

Avg 1 year Forecast
$3.8B+4.1%
Avg 2 year Forecast
$4.0B+8.21%
DBD's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

DBD revenue growth forecast

How is DBD forecast to perform vs Software - Application companies and vs the US market?

Company
4.1%
Industry
7.95%
Market
126.6%
DBD's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
DBD's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

DBD vs App Stocks

TickerPricePrice TargetUp/downsideConsensus
DBD$59.10$75.00+26.90%Strong Buy
DV$12.97$18.97+46.24%Buy
PRCH$18.09$16.67-7.87%Strong Buy
PLUS$74.77N/AN/A
AI$17.24$22.18+28.67%Hold
View Top App Stocks

Diebold Nixdorf Stock Forecast FAQ

Is Diebold Nixdorf Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NYSE: DBD) stock is to Strong Buy DBD stock.

Out of 2 analysts, 1 (50%) are recommending DBD as a Strong Buy, 1 (50%) are recommending DBD as a Buy, 0 (0%) are recommending DBD as a Hold, 0 (0%) are recommending DBD as a Sell, and 0 (0%) are recommending DBD as a Strong Sell.

If you're new to stock investing, here's how to buy Diebold Nixdorf stock.

What is DBD's earnings growth forecast for 2025-2026?

(NYSE: DBD) Diebold Nixdorf's forecast annual earnings growth rate of N/A is not forecast to beat the US Software - Application industry's average forecast earnings growth rate of 12.14%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 54.26%.

Diebold Nixdorf's earnings in 2025 is -$12,900,000.On average, 1 Wall Street analyst forecast DBD's earnings for 2025 to be $127,118,398, with the lowest DBD earnings forecast at $127,118,398, and the highest DBD earnings forecast at $127,118,398.

In 2026, DBD is forecast to generate $220,533,935 in earnings, with the lowest earnings forecast at $220,533,935 and the highest earnings forecast at $220,533,935.

What is DBD's revenue growth forecast for 2025-2026?

(NYSE: DBD) Diebold Nixdorf's forecast annual revenue growth rate of 4.1% is not forecast to beat the US Software - Application industry's average forecast revenue growth rate of 7.95%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 126.6%.

Diebold Nixdorf's revenue in 2025 is $3,672,300,000.On average, 1 Wall Street analysts forecast DBD's revenue for 2025 to be $140,042,712,003, with the lowest DBD revenue forecast at $140,042,712,003, and the highest DBD revenue forecast at $140,042,712,003.

In 2026, DBD is forecast to generate $145,570,713,793 in revenue, with the lowest revenue forecast at $145,570,713,793 and the highest revenue forecast at $145,570,713,793.

What is DBD's forecast return on assets (ROA) for 2025-2026?

(NYSE: DBD) forecast ROA is 5.9%, which is lower than the forecast US Software - Application industry average of 15.65%.

What is DBD's Price Target?

According to 2 Wall Street analysts that have issued a 1 year DBD price target, the average DBD price target is $75.00, with the highest DBD stock price forecast at $80.00 and the lowest DBD stock price forecast at $70.00.

On average, Wall Street analysts predict that Diebold Nixdorf's share price could reach $75.00 by Aug 19, 2026. The average Diebold Nixdorf stock price prediction forecasts a potential upside of 26.9% from the current DBD share price of $59.10.

What is DBD's Earnings Per Share (EPS) forecast for 2025-2026?

(NYSE: DBD) Diebold Nixdorf's current Earnings Per Share (EPS) is -$0.34. On average, analysts forecast that DBD's EPS will be $3.47 for 2025, with the lowest EPS forecast at $3.47, and the highest EPS forecast at $3.47. In 2026, DBD's EPS is forecast to hit $6.02 (min: $6.02, max: $6.02).

What is DBD's forecast return on equity (ROE) for 2025-2026?

(NYSE: DBD) forecast ROE is 20.1%, which is considered strong.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.